Benefits and risks of postmenopausal hormone therapy: Two expert opinions
New options and additional information add perspective By Hugh S. Taylor, MD Dr. Taylor is the Anita O'Keeffe Young Professor and Chair, Department of Obstetrics, Gynecology and Reproductive Sciences,...
View ArticleUntreated hot flashes may impact work productivity
Many women who suffer from moderate to severe vasomotor symptoms (VMS) appear to go untreated, potentially leading to work loss, according to a new study in Menopause. Researchers at Yale School of...
View ArticleManagement of mood and memory problems during menopause
More than 20% of the US population will suffer from an episode of depression, and women have a 2-fold greater risk than men.1 Several large prospective trials have shown an increased risk of depressed...
View ArticleAre severe menopause symptoms a bellwether of bone health?
Women with more severe vasomotor symptoms (VMS) and night sweats may be at risk of having poorer bone health, according to a prospective observational study based on data from the Women’s Health...
View ArticleAre common chemicals associated with earlier onset of menopause?
A study of a representative sample of US women shows a clinically significant association between early menopause and exposure to 15 different endocrine-disrupting chemicals (EDCs) commonly found in...
View ArticleMenopause counseling hot flash: Persistent VMS more common in...
Vasomotor symptoms (VMS) during menopause may last much longer than previously had been thought, according to analysis of data from a multiyear, multiracial/multiethnic observational study. The Study...
View ArticleNewborn PPH from antidepressant use?
Newborn PPH from antidepressant use? A cohort study in a large group of publicly insured women seems to indicate that using selective serotonin reuptake inhibitors (SSRI) late in pregnancy may...
View ArticleRamifications of pelvic exam guidelines
The 2009 change in cervical cancer screening guidelines may have had an unintended consequence: fewer young women are receiving the annual chlamydia screening recommended by the Centers for Disease...
View ArticleNew data show no miscarriage link for HPV vaccination
A study by investigators from Costa Rica and the National Cancer Institute provides reassurance about the safety of human papillomavirus (HPV) vaccination for women who may become pregnant soon after...
View ArticleOsteoporosis and periodontal disease in menopause
Postmenopausal osteoporosis is not associated with increased periodontitis, according to results of a small study by European researchers. It is, however, significantly associated with tooth loss,...
View ArticleImpact of menopause on migraine frequency
Women who are approaching menopause may experience an increased number of migraine headaches, according to a new observational study published in Headache: The Journal of Head and Face Pain, a...
View ArticleFDA approves morcellation containment system
The US Food and Drug Administration (FDA) has given the nod to a first-of-its-kind tissue containment system for use with certain laparoscopic power morcellators. Advanced Surgical Concepts Ltd., the...
View ArticleDo ovary-sparing hysterectomies lead to early menopause?
Women who undergo an ovary-sparing hysterectomy may be at a greater risk of early onset of menopause, according to a secondary analysis from the Prospective Research on Ovarian Function study.More: 11...
View ArticleDo flame retardants increase risk of thyroid disease?
Women who have been exposed to polybrominated diphenyl esters (PBDEs)—common chemicals used as flame retardants—may have a higher risk of thyroid disease, according to results of a study in...
View ArticleCan low-dose estrogen bring vasomotor symptom relief?
Lower-than-conventional doses of oral or transdermal estrogen may be very effective in treating vasomotor symptoms in menopausal women, according to a new study in Menopause. The study looked at 727...
View ArticleHow quality measures can decrease cesareans
A new study in The Joint Commission Journal of Quality and Safety led by researchers at Beth Israel Deaconess Medical Center (BIDMC) indicates that hospital-led interventions over the course of 7...
View ArticleNatural estrogen/progesterone HT capsule shows promise
A first-of-its-kind capsule combining natural 17β-estradiol and progesterone has promise for menopause-related hot flushes, according to results of a Phase 3 multicenter trial presented at the 65th...
View ArticleTools Test Drive: Sureglide, Überlube, and TruClear
Sureglide Background Creating a hysterotomy during cesarean delivery is as basic a skill as exists in the practice of obstetrics. Unfortunately, about 0.7% to 1.9% of the time while cutting into the...
View ArticleMigraines in Women
Headache is among the most common neurological conditions with a current worldwide prevalence in the general population of 47%.1 The Global Burden of Disease Study 2015 ranks headache disorders...
View ArticleImpact of aspirin in reducing preterm preeclampsia
Low-dose aspirin may be beneficial for women who are at high risk of developing preterm preeclampsia, according to results of a multicenter, double-blind trial published in The New England Journal of...
View ArticleMenopause updates
NICE guidelines on menopause Guidelines from the National Institute for Health and Care Excellence (NICE) offer a unique perspective on diagnosis and management of menopause, designed to help women...
View ArticleLate Menopause May Link to Reduced Risk of Diabetes
Going into menopause later in life might be associated with an unexpected benefit—a lower risk of developing type 2 diabetes. A recent prospective study found that women who entered menopause before...
View ArticleWhy Are Women Choosing Bioidentical Hormone Therapy?
An estimated one in three women are currently treating menopause symptoms by using compounded bioidentical hormone therapy (CBHT) rather than conventional FDA-approved hormone therapy (HT). A recent...
View ArticleOveractive bladder: Special considerations across a woman’s life span
Judy Yeh, MDToby C. Chai, MD Introduction Bladder health is an important component of a woman’s well-being,1 and overactive bladder (OAB) remains a multifactorial symptom complex that gynecologists are...
View ArticleFlibanserin can cause weight loss in pre/postmenopausal women with HSDD
Premenopausal and postmenopausal women treated with the combined agonist/antagonist flibanserin for hypoactive sexual desire disorder (HSDD) are likely to lose weight, according to a post hoc analysis...
View Article